# FDA Approves Gland Pharma's Generic Ketamine Hydrochloride Injection Gland Pharma Limited received FDA approval for its generic ketamine hydrochloride intramuscular injection, expanding the competitive generic market for this widely-used anesthetic and therapeutic agent. The approval is expected to increase price competition and improve patient access to ketamine formulations across hospital and clinical settings.